A Multi-center Clinical Study of Zanubrutinib in Combination With First-line Chemoimmunotherapy in Patients With Grade 3A High-risk Follicular Lymphoma

NCT06742879 · clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
37
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Zhengzhou University